BRIEF-ARCA Biopharma announces database lock for genetic-af phase 2b interim efficacy analysis
June 20, 2017 at 09:14 AM EDT
* ARCA Biopharma announces database lock for genetic-af phase 2b interim efficacy analysis – dsmb recommendation anticipated in august 2017 Source text for Eikon: Further company coverage:
